| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |